Navigation Links
Cutting the Cost of Clinical Research: The Solution Comes from Russia, New Xtalks Webinar
Date:2/5/2013

Toronto, Canada (PRWEB) February 05, 2013

A patriarch of randomized clinical trials in Russia, Dr. Sergei Varshavsky, in his signature provocative manner, will discuss the problem of the high price that governments and societies pay for development of new cures.

Dr. Varshavsky will provide valuable insights into the roles played by different interest groups in raising the price of clinical trials over the past two decades. He will analyze the nature, causes and consequences of the major components of that cost, as well as propose an optimistic vision for a way out.

Also, Mr. Igor Stefanov, a proponent of openness and transparency in the CRO business, will analyze the current state of the clinical trials market in Russia and review the upcoming trends as well as historical data. His report will follow SynRG's Orange Paper and discuss the new regulatory initiatives that may affect the players and influence the future landscape. Figures and tables will provide valuable data for risk-benefit analysis and decision-making.

A live Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit: http://xtks.in/xto562-event

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/2/prweb10385980.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
2. Cutting the graphene cake
3. JoVE partners with US government to publish cutting-edge defense research
4. Frost & Sullivan Announces Cutting Edge Life Sciences Research on the Horizon
5. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
6. OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)
7. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
8. Migraines Found Linked to Nighttime Teeth Grinding & Clenching in TMJ Treatment Clinical Trial - Holistic Technologies
9. MC Leeuwarden Selects ClinicalKey
10. ComplianceOnline Announces Seminar on Clinical Trial Project Supplier Quality Improvement
11. MDA Launches Clinical Network to Speed Myotonic Dystrophy Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... BioMedGPS announces expanded coverage of SmartTRAK Business ... US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and Sealants module ... and biologic sealants used in surgical applications. BioMedGPS estimates the market will grow ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):